DocDollars

Celgene Corporation

NJ · United States · Reporting entity ID 100000000343

Total reported 2019–2025
$687.8M
#27 of 2,960 reporting companies — 0.8% of all reported industry payments
$81.2M in general payments across 383,886 records, plus $606.7M in research funding across 15,087 records.

How it breaks down

General payments $81,172,605
Research funding $606,650,713

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Celgene Corporation reported $687.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #27 of 2,960 reporting companies. 88% of that was research funding and 12% general payments such as consulting, speaking, food and travel. 383,886 general payment records and 15,087 research records were filed.

Common questions about Celgene Corporation

How much has Celgene Corporation paid US doctors?

Celgene Corporation reported $687,823,318 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $81,172,605 in general payments, $606,650,713 in research funding.

How does Celgene Corporation rank among drug and device companies?

It ranks #27 of 2,960 reporting entities by total reported value, about 0.8% of all industry payments in the dataset.

Does a payment from Celgene Corporation mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.